Shelley Hartman

Company: Aegle Therapeutics

Job title: Chief Executive Officer

Bio:

Shelley Hartman is a co-founder of Aegle Therapeutics and became Chief Executive Officer in 2019. Prior to Aegle, Ms. Hartman was the Chairman and CEO of LifeSync Corporation, a start-up medical device company. LifeSync was spun out of GMP Companies, Inc. where Ms. Hartman served as the CEO. GMP was founded by investors including TPG, Medtronic and P&G Pharma to advance early-stage biopharmaceutical and medical device product development. Before joining GMP, Ms. Hartman was an investment banker for 19 years, the last seven as a Managing Director at Goldman, Sachs & Co., servicing healthcare/life science clients. Ms. Hartman holds a B.A. from Wellesley College.

Seminars:

Clinical Advances in EV Therapies 12:00 pm

Updating the field on Aegle’s therapeutic clinical progress Highlighting where we go from here and overcoming key challenges NEW DATA!Read more

day: Conference Day One

Biopharma Leaders Panel Discussion: Unlocking the Next Wave of Safe & Efficient Exosome-Based Therapeutics Towards Clinical & Commercial Reality 1:30 pm

This is your chance to hear from pioneering executive leaders from the exosome and extra-cellular vesicle community who will discuss their strategies, challenges, and future perspectives for exosome technology and clinically relevant therapeutic applications. What are the future opportunities, promising targets, and applications on the horizon for exosomes to achieve clinical success? What can we…Read more

day: Conference Day One